Skip to main content

Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001369568

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Catalyst Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
190
+8 vs. Q1 2022
Shares held
75.5M
+5.36M (+7.6%) vs. Q1 2022
Total value
$531.7M
−$49.0M (−8.4%) vs. Q1 2022
New holders
25
60 more added
Sold out
17
72 more reduced

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 190 institutions
Q1 2021: 133 institutionsQ2 2021: 139 institutionsQ3 2021: 144 institutionsQ4 2021: 164 institutionsQ1 2022: 186 institutionsQ2 2022: 190 institutionsQ3 2022: 229 institutionsQ4 2022: 257 institutionsQ1 2023: 260 institutionsQ2 2023: 248 institutionsQ3 2023: 256 institutionsQ4 2023: 259 institutionsQ1 2024: 268 institutionsQ2 2024: 271 institutionsQ3 2024: 316 institutionsQ4 2024: 336 institutionsQ1 2025: 370 institutionsQ2 2025: 365 institutionsQ3 2025: 360 institutionsQ4 2025: 375 institutionsQ1 2026: 382 institutionsQ2 2026: 395 institutions
Value heldQ2 2022: $531.7M
Q1 2021: $312.0MQ2 2021: $376.6MQ3 2021: $345.1MQ4 2021: $446.7MQ1 2022: $585.5MQ2 2022: $531.7MQ3 2022: $1.09BQ4 2022: $1.56BQ1 2023: $1.47BQ2 2023: $1.11BQ3 2023: $948.8MQ4 2023: $1.42BQ1 2024: $1.53BQ2 2024: $1.50BQ3 2024: $1.90BQ4 2024: $2.04BQ1 2025: $2.37BQ2 2025: $2.20BQ3 2025: $2.04BQ4 2025: $2.43BQ1 2026: $2.59BQ2 2026: $3.39B
Institutions holding CPRX and their total value by quarter
QuarterHoldersValue
Q2 2026395$3.39B
Q1 2026382$2.59B
Q4 2025375$2.43B
Q3 2025360$2.04B
Q2 2025365$2.20B
Q1 2025370$2.37B
Q4 2024336$2.04B
Q3 2024316$1.90B
Q2 2024271$1.50B
Q1 2024268$1.53B
Q4 2023259$1.42B
Q3 2023256$948.8M
Q2 2023248$1.11B
Q1 2023260$1.47B
Q4 2022257$1.56B
Q3 2022229$1.09B
Q2 2022190$531.7M
Q1 2022186$585.5M
Q4 2021164$446.7M
Q3 2021144$345.1M
Q2 2021139$376.6M
Q1 2021133$312.0M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding CPRX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
GWM Advisors LLC0$00.00%−19,189−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−15,597−100.0%Sold out
USA Financial Portformulas Corp0$00.00%−12,870−100.0%Sold out
Nkcfo LLC0$00.00%−12,000−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−10,941−100.0%Sold out
Group One Trading, L.P.0$00.00%−9,242−100.0%Sold out
Quantbot Technologies LP0$00.00%−7,500−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Virginia Retirement Systems Et Al––––Not filed
IndexIQ Advisors LLC––––Not filed
Amalgamated Financial Corp.––––Not filed